LC–MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood

Hiemke, 2011, AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011, Pharmacopsychiatry, 44, 195, 10.1055/s-0031-1286287 Fisher, 2013, Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples, Ther. Drug Monit., 10.1097/FTD.0b013e318283eaf2 Patsalos, 2013, Therapeutic drug monitoring of antiepileptic drugs by use of saliva, Ther. Drug Monit., 35, 4, 10.1097/FTD.0b013e31827c11e7 Zhao, 2011, Principles of therapeutic drug monitoring, Handb. Exp. Pharmacol., 205, 77, 10.1007/978-3-642-20195-0_3 Uřinovská, 2012, Liquid chromatography-tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 907, 101, 10.1016/j.jchromb.2012.09.009 Titier, 2003, High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 788, 179, 10.1016/S1570-0232(02)01003-6 Sachse, 2006, Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 830, 342, 10.1016/j.jchromb.2005.11.032 Remane, 2011, Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs, Anal. Bioanal. Chem., 401, 1341, 10.1007/s00216-011-5187-9 Patel, 2012, LC–MS/MS assay for olanzapine in human plasma and its application to a bioequivalence study, Acta Pharmaceut. Sinic. B, 2, 481, 10.1016/j.apsb.2012.02.009 Saar, 2012, The analysis of antipsychotic drugs in human matrices using LC–MS(/MS), Drug Test. Anal., 4, 376, 10.1002/dta.1337 Madej, 2009, Study of separation and extraction conditions for five neuroleptic drugs by an LLE-HPLC-DAD method in human plasma, J. Liq. Chromatogr. R. T., 32, 3025, 10.1080/10826070903320582 FDA/CDER, Guidance for industry: bioanalytical method validation. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf, 2001 (accessed 18.07.11). D. Tholen, A. Kallner, J. Kennedy, J.S. Krouwer, K. Meier, Evaluation of precision performance of quantitative measurement methods; Approved Guideline–Second Edition. Available at: http://webstore.ansi.org/ansidocstore/product.asp?sku=EP05%2DA2, 2004 (accessed 10.07.12). Bonfiglio, 1999, The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds, Rapid Commun. Mass Spectrom., 13, 1175, 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0 D.S. Fisher, S.J. Partridge, S.A. Handley, R.J. Flanagan, Stability of some atypical antipsychotics in human plasma, human serum, calf serum, oral fluid and haemolysed whole blood, submitted for publication. Fisher, 2012, Measurement of quetiapine and four quetiapine metabolites in human plasma by LC–MS/MS, Biomed. Chromatogr., 26, 1125, 10.1002/bmc.2672 Flanagan, 2008, Therapeutic monitoring of antipsychotic drugs, Internat. Labmate., 33, 6 Saar, 2010, Identification and quantification of 30 antipsychotics in blood using LC–MS/MS, J. Mass Spectrom., 45, 915, 10.1002/jms.1783 Kratzsch, 2003, Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization, J. Mass Spectrom., 38, 283, 10.1002/jms.440 Flanagan, 2003, Comparability of whole-blood and plasma clozapine and norclozapine concentrations, Br. J. Clin. Pharmacol., 56, 135, 10.1046/j.1365-2125.2003.01821.x